Skip to content
Recall Observatory FDA recall evidence

Drug product

Optic Splash (naphazoline hydrochloride) Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Manufactured by SATO Pharmaceuticals CO., LTD. 1-5-27 Motoakasaka Minato-Ku Tokyo, Japan, NDC 49873-501-01.

D-0854-2017

February 16, 2017

Class II

Product summary

Firm
Sato Pharmaceutical Inc.
Event
Event 77161
Status
Terminated
Classification
Class II
Quantity
10,130 bottles
Official record key
drug-enforcement:D-0854-2017

Official wording

Reason: Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Code information: Lot #: XXWC, Exp. August 2018

Distribution pattern: US: Hawaii, Guam, Saipan, SPI

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility